nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—ADRA1D—epithelium—cervical cancer	0.0135	0.0482	CbGeAlD
Lisuride—ADRA1B—renal system—cervical cancer	0.0128	0.0457	CbGeAlD
Lisuride—DRD5—female reproductive system—cervical cancer	0.0125	0.0447	CbGeAlD
Lisuride—DRD5—female gonad—cervical cancer	0.0113	0.0407	CbGeAlD
Lisuride—ADRA1D—female reproductive system—cervical cancer	0.00999	0.0358	CbGeAlD
Lisuride—HTR2B—uterine cervix—cervical cancer	0.00927	0.0333	CbGeAlD
Lisuride—HTR2B—decidua—cervical cancer	0.00884	0.0317	CbGeAlD
Lisuride—HTR2B—endometrium—cervical cancer	0.00839	0.0301	CbGeAlD
Lisuride—HTR1A—renal system—cervical cancer	0.00777	0.0279	CbGeAlD
Lisuride—HTR2B—uterus—cervical cancer	0.00773	0.0277	CbGeAlD
Lisuride—HTR1B—female reproductive system—cervical cancer	0.00772	0.0277	CbGeAlD
Lisuride—HTR1D—female reproductive system—cervical cancer	0.00747	0.0268	CbGeAlD
Lisuride—HTR2C—female reproductive system—cervical cancer	0.0074	0.0265	CbGeAlD
Lisuride—ADRA2C—uterine cervix—cervical cancer	0.0073	0.0262	CbGeAlD
Lisuride—ADRB1—female reproductive system—cervical cancer	0.00726	0.026	CbGeAlD
Lisuride—ADRA2C—decidua—cervical cancer	0.00696	0.0249	CbGeAlD
Lisuride—HTR2B—female reproductive system—cervical cancer	0.00695	0.0249	CbGeAlD
Lisuride—ADRA2C—renal system—cervical cancer	0.00683	0.0245	CbGeAlD
Lisuride—ADRA2C—endometrium—cervical cancer	0.0066	0.0237	CbGeAlD
Lisuride—ADRA2C—mammalian vulva—cervical cancer	0.00639	0.0229	CbGeAlD
Lisuride—HTR2B—vagina—cervical cancer	0.00628	0.0225	CbGeAlD
Lisuride—ADRA2C—uterus—cervical cancer	0.00608	0.0218	CbGeAlD
Lisuride—ADRA2A—uterine cervix—cervical cancer	0.00582	0.0209	CbGeAlD
Lisuride—ADRA2A—decidua—cervical cancer	0.00555	0.0199	CbGeAlD
Lisuride—ADRA2A—endometrium—cervical cancer	0.00527	0.0189	CbGeAlD
Lisuride—ADRA2A—mammalian vulva—cervical cancer	0.0051	0.0183	CbGeAlD
Lisuride—HTR2A—epithelium—cervical cancer	0.005	0.0179	CbGeAlD
Lisuride—ADRA2C—female gonad—cervical cancer	0.00498	0.0178	CbGeAlD
Lisuride—ADRA2C—vagina—cervical cancer	0.00495	0.0177	CbGeAlD
Lisuride—ADRA2A—uterus—cervical cancer	0.00485	0.0174	CbGeAlD
Lisuride—HTR2A—renal system—cervical cancer	0.00463	0.0166	CbGeAlD
Lisuride—ADRA2A—female reproductive system—cervical cancer	0.00436	0.0156	CbGeAlD
Lisuride—CYP3A4—renal system—cervical cancer	0.00429	0.0154	CbGeAlD
Lisuride—CYP2D6—renal system—cervical cancer	0.00422	0.0151	CbGeAlD
Lisuride—HTR2B—lymph node—cervical cancer	0.00407	0.0146	CbGeAlD
Lisuride—ADRA2A—female gonad—cervical cancer	0.00397	0.0142	CbGeAlD
Lisuride—ADRA2A—vagina—cervical cancer	0.00395	0.0142	CbGeAlD
Lisuride—HTR2A—female reproductive system—cervical cancer	0.00371	0.0133	CbGeAlD
Lisuride—CYP3A4—female reproductive system—cervical cancer	0.00344	0.0123	CbGeAlD
Lisuride—CYP2D6—female reproductive system—cervical cancer	0.00338	0.0121	CbGeAlD
Lisuride—HTR2A—vagina—cervical cancer	0.00336	0.012	CbGeAlD
Lisuride—ADRA2C—lymph node—cervical cancer	0.0032	0.0115	CbGeAlD
Lisuride—CYP2D6—female gonad—cervical cancer	0.00308	0.011	CbGeAlD
Lisuride—ADRA2A—lymph node—cervical cancer	0.00255	0.00915	CbGeAlD
Lisuride—DRD3—Signaling Pathways—AKAP13—cervical cancer	0.000466	0.000646	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TAAR6—cervical cancer	0.000465	0.000645	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—WNT2—cervical cancer	0.000462	0.000641	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—WNT2—cervical cancer	0.00046	0.000638	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—WNT5A—cervical cancer	0.00046	0.000638	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—WNT5A—cervical cancer	0.000453	0.000628	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—WNT2—cervical cancer	0.000447	0.00062	CbGpPWpGaD
Lisuride—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000446	0.000619	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—WNT2—cervical cancer	0.00044	0.000611	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—WNT5A—cervical cancer	0.000432	0.000599	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—NOTCH2—cervical cancer	0.00043	0.000597	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—AKAP13—cervical cancer	0.000424	0.000588	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—AKAP13—cervical cancer	0.00042	0.000583	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—CA9—cervical cancer	0.00041	0.000569	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—WNT5A—cervical cancer	0.000407	0.000565	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—WNT2—cervical cancer	0.000406	0.000563	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—AKAP13—cervical cancer	0.000406	0.000563	CbGpPWpGaD
Lisuride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000405	0.000561	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—AKAP13—cervical cancer	0.000404	0.00056	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—WNT5A—cervical cancer	0.000402	0.000557	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—WNT5A—cervical cancer	0.000402	0.000557	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—WNT2—cervical cancer	0.000399	0.000554	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—AKAP13—cervical cancer	0.000393	0.000545	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—AKAP13—cervical cancer	0.000387	0.000536	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—WNT5A—cervical cancer	0.000366	0.000508	CbGpPWpGaD
Lisuride—DRD2—Circadian rythm related genes—TP53—cervical cancer	0.000365	0.000506	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—WNT2—cervical cancer	0.000363	0.000504	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—WNT5A—cervical cancer	0.000363	0.000503	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—AKAP13—cervical cancer	0.000356	0.000494	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—HES1—cervical cancer	0.000353	0.000489	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—AKAP13—cervical cancer	0.000351	0.000486	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—WNT5A—cervical cancer	0.00035	0.000486	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—WNT5A—cervical cancer	0.000349	0.000483	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—WNT5A—cervical cancer	0.000339	0.00047	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—WNT5A—cervical cancer	0.000334	0.000463	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—NOTCH2—cervical cancer	0.00033	0.000457	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—NOTCH2—cervical cancer	0.000323	0.000448	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—AKAP13—cervical cancer	0.000319	0.000442	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—NOTCH2—cervical cancer	0.000318	0.00044	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—TERT—cervical cancer	0.000309	0.000429	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—WNT5A—cervical cancer	0.000308	0.000427	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—NOTCH2—cervical cancer	0.000303	0.00042	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—WNT5A—cervical cancer	0.000303	0.00042	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—NOTCH2—cervical cancer	0.000286	0.000397	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—FGFR3—cervical cancer	0.000284	0.000393	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—NOTCH2—cervical cancer	0.000282	0.000391	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—NOTCH2—cervical cancer	0.000282	0.000391	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—WNT5A—cervical cancer	0.000275	0.000382	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—HES1—cervical cancer	0.00027	0.000375	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—CA9—cervical cancer	0.000267	0.000371	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—NOTCH1—cervical cancer	0.000266	0.000369	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—HES1—cervical cancer	0.000265	0.000367	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—HES1—cervical cancer	0.00026	0.000361	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—NOTCH2—cervical cancer	0.000257	0.000356	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—NOTCH2—cervical cancer	0.000255	0.000353	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—HES1—cervical cancer	0.000249	0.000345	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	0.000246	0.000341	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	0.000245	0.000339	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—NOTCH2—cervical cancer	0.000238	0.00033	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—EGFR—cervical cancer	0.000237	0.000329	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—TERT—cervical cancer	0.000237	0.000328	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—HES1—cervical cancer	0.000234	0.000325	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—NOTCH2—cervical cancer	0.000234	0.000325	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TERT—cervical cancer	0.000232	0.000322	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—HES1—cervical cancer	0.000231	0.000321	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—HES1—cervical cancer	0.000231	0.000321	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TERT—cervical cancer	0.000228	0.000316	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TERT—cervical cancer	0.000218	0.000302	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—FGFR3—cervical cancer	0.000217	0.000301	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—NOTCH2—cervical cancer	0.000216	0.000299	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—FGFR3—cervical cancer	0.000213	0.000295	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	0.000212	0.000295	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—HES1—cervical cancer	0.000211	0.000292	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—FGFR3—cervical cancer	0.000209	0.00029	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—HES1—cervical cancer	0.000209	0.00029	CbGpPWpGaD
Lisuride—ADRA2B—Hemostasis—TP53—cervical cancer	0.000206	0.000285	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TERT—cervical cancer	0.000205	0.000285	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—MTHFR—cervical cancer	0.000205	0.000284	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—NOTCH1—cervical cancer	0.000204	0.000283	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TERT—cervical cancer	0.000203	0.000281	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TERT—cervical cancer	0.000203	0.000281	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—HES1—cervical cancer	0.000202	0.00028	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—HES1—cervical cancer	0.000201	0.000278	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—FGFR3—cervical cancer	0.0002	0.000277	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—NOTCH1—cervical cancer	0.0002	0.000277	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—MTOR—cervical cancer	0.0002	0.000277	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—NOTCH1—cervical cancer	0.000197	0.000273	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—HES1—cervical cancer	0.000195	0.000271	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	0.000193	0.000268	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—HES1—cervical cancer	0.000192	0.000266	CbGpPWpGaD
Lisuride—ADRA2C—Hemostasis—TP53—cervical cancer	0.000192	0.000266	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—FGFR3—cervical cancer	0.000189	0.000261	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—NOTCH1—cervical cancer	0.000188	0.00026	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—FGFR3—cervical cancer	0.000186	0.000258	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—FGFR3—cervical cancer	0.000186	0.000258	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TERT—cervical cancer	0.000185	0.000256	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—CASP3—cervical cancer	0.000184	0.000255	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TERT—cervical cancer	0.000183	0.000254	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—EGFR—cervical cancer	0.000182	0.000252	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—EGFR—cervical cancer	0.000178	0.000247	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—HES1—cervical cancer	0.000177	0.000245	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—NOTCH1—cervical cancer	0.000177	0.000245	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—CTNNB1—cervical cancer	0.000177	0.000245	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TERT—cervical cancer	0.000177	0.000245	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TERT—cervical cancer	0.000176	0.000244	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—EGFR—cervical cancer	0.000175	0.000243	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CA9—cervical cancer	0.000175	0.000242	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—NOTCH1—cervical cancer	0.000175	0.000242	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—NOTCH1—cervical cancer	0.000175	0.000242	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—HES1—cervical cancer	0.000174	0.000242	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TERT—cervical cancer	0.000171	0.000237	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—FGFR3—cervical cancer	0.000169	0.000235	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TERT—cervical cancer	0.000168	0.000233	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—FGFR3—cervical cancer	0.000168	0.000233	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—EGFR—cervical cancer	0.000167	0.000232	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—MTHFR—cervical cancer	0.000167	0.000231	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—FGFR3—cervical cancer	0.000162	0.000225	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—FGFR3—cervical cancer	0.000161	0.000224	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—NOTCH1—cervical cancer	0.000159	0.000221	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—HES1—cervical cancer	0.000158	0.00022	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—EGFR—cervical cancer	0.000158	0.000219	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—NOTCH1—cervical cancer	0.000158	0.000219	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—FGFR3—cervical cancer	0.000157	0.000218	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—TP53—cervical cancer	0.000156	0.000216	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—EGFR—cervical cancer	0.000156	0.000216	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—EGFR—cervical cancer	0.000156	0.000216	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TERT—cervical cancer	0.000155	0.000215	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—FGFR3—cervical cancer	0.000154	0.000214	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—STAT3—cervical cancer	0.000154	0.000214	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—MTOR—cervical cancer	0.000153	0.000212	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TERT—cervical cancer	0.000153	0.000212	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	0.000152	0.000211	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	0.000151	0.00021	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—MTOR—cervical cancer	0.00015	0.000208	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—MTOR—cervical cancer	0.000147	0.000204	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—NOTCH1—cervical cancer	0.000147	0.000204	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—NOTCH1—cervical cancer	0.000145	0.000201	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—FGFR3—cervical cancer	0.000142	0.000197	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—EGFR—cervical cancer	0.000142	0.000197	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—MTOR—cervical cancer	0.000141	0.000195	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CASP3—cervical cancer	0.000141	0.000195	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—EGFR—cervical cancer	0.00014	0.000195	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—EGFR—cervical cancer	0.00014	0.000194	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—FGFR3—cervical cancer	0.00014	0.000194	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TERT—cervical cancer	0.000139	0.000193	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CASP3—cervical cancer	0.000138	0.000191	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—EGFR—cervical cancer	0.000136	0.000188	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CTNNB1—cervical cancer	0.000136	0.000188	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CASP3—cervical cancer	0.000136	0.000188	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—EGFR—cervical cancer	0.000135	0.000187	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—NOTCH1—cervical cancer	0.000134	0.000185	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CTNNB1—cervical cancer	0.000133	0.000184	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—MTOR—cervical cancer	0.000133	0.000184	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	0.000131	0.000182	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—EGFR—cervical cancer	0.000131	0.000182	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—MTOR—cervical cancer	0.000131	0.000181	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—MTOR—cervical cancer	0.000131	0.000181	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CTNNB1—cervical cancer	0.000131	0.000181	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CASP3—cervical cancer	0.000129	0.000179	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—EGFR—cervical cancer	0.000129	0.000179	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	0.000127	0.000177	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CTNNB1—cervical cancer	0.000125	0.000173	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CASP3—cervical cancer	0.000122	0.000169	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CASP3—cervical cancer	0.00012	0.000167	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CASP3—cervical cancer	0.00012	0.000167	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	0.00012	0.000166	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—MTOR—cervical cancer	0.000119	0.000165	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—EGFR—cervical cancer	0.000119	0.000165	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—STAT3—cervical cancer	0.000118	0.000164	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—MTOR—cervical cancer	0.000118	0.000164	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—TP53—cervical cancer	0.000118	0.000163	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CTNNB1—cervical cancer	0.000118	0.000163	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—EGFR—cervical cancer	0.000117	0.000162	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CTNNB1—cervical cancer	0.000116	0.000161	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CTNNB1—cervical cancer	0.000116	0.000161	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—STAT3—cervical cancer	0.000116	0.00016	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—MTOR—cervical cancer	0.000114	0.000158	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—STAT3—cervical cancer	0.000114	0.000158	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—MTOR—cervical cancer	0.000113	0.000157	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—MTOR—cervical cancer	0.00011	0.000153	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CASP3—cervical cancer	0.00011	0.000152	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—STAT3—cervical cancer	0.000109	0.000151	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CASP3—cervical cancer	0.000109	0.000151	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—MTOR—cervical cancer	0.000109	0.000151	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—MTHFR—cervical cancer	0.000109	0.00015	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—EGFR—cervical cancer	0.000107	0.000149	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	0.000107	0.000148	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CTNNB1—cervical cancer	0.000106	0.000147	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—EGFR—cervical cancer	0.000105	0.000146	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CASP3—cervical cancer	0.000105	0.000145	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CTNNB1—cervical cancer	0.000105	0.000145	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CASP3—cervical cancer	0.000104	0.000145	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—EGFR—cervical cancer	0.000103	0.000144	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—STAT3—cervical cancer	0.000102	0.000142	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CASP3—cervical cancer	0.000102	0.000141	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—STAT3—cervical cancer	0.000101	0.00014	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—STAT3—cervical cancer	0.000101	0.00014	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	0.000101	0.00014	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	0.000101	0.000139	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—MTOR—cervical cancer	0.0001	0.000139	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CASP3—cervical cancer	9.99e-05	0.000139	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—EGFR—cervical cancer	9.88e-05	0.000137	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—MTOR—cervical cancer	9.85e-05	0.000137	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CTNNB1—cervical cancer	9.78e-05	0.000136	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CTNNB1—cervical cancer	9.63e-05	0.000134	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—EGFR—cervical cancer	9.32e-05	0.000129	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—STAT3—cervical cancer	9.21e-05	0.000128	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CASP3—cervical cancer	9.21e-05	0.000128	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—EGFR—cervical cancer	9.19e-05	0.000127	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—EGFR—cervical cancer	9.19e-05	0.000127	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—STAT3—cervical cancer	9.13e-05	0.000127	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CASP3—cervical cancer	9.06e-05	0.000126	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—TP53—cervical cancer	9.02e-05	0.000125	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—MTOR—cervical cancer	8.96e-05	0.000124	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CTNNB1—cervical cancer	8.88e-05	0.000123	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TP53—cervical cancer	8.83e-05	0.000122	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—STAT3—cervical cancer	8.81e-05	0.000122	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—STAT3—cervical cancer	8.77e-05	0.000122	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	8.74e-05	0.000121	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TP53—cervical cancer	8.69e-05	0.00012	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—STAT3—cervical cancer	8.53e-05	0.000118	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—STAT3—cervical cancer	8.39e-05	0.000116	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—EGFR—cervical cancer	8.37e-05	0.000116	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—EGFR—cervical cancer	8.3e-05	0.000115	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TP53—cervical cancer	8.29e-05	0.000115	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CASP3—cervical cancer	8.24e-05	0.000114	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—EGFR—cervical cancer	8.01e-05	0.000111	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—EGFR—cervical cancer	7.97e-05	0.000111	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	7.95e-05	0.00011	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TP53—cervical cancer	7.82e-05	0.000108	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—EGFR—cervical cancer	7.75e-05	0.000107	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—STAT3—cervical cancer	7.74e-05	0.000107	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TP53—cervical cancer	7.72e-05	0.000107	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TP53—cervical cancer	7.72e-05	0.000107	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—EGFR—cervical cancer	7.63e-05	0.000106	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—STAT3—cervical cancer	7.61e-05	0.000106	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—MTHFR—cervical cancer	7.09e-05	9.84e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—EGFR—cervical cancer	7.03e-05	9.75e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TP53—cervical cancer	7.03e-05	9.75e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TP53—cervical cancer	6.97e-05	9.66e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—STAT3—cervical cancer	6.93e-05	9.61e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—EGFR—cervical cancer	6.92e-05	9.6e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TP53—cervical cancer	6.73e-05	9.33e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TP53—cervical cancer	6.69e-05	9.28e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TP53—cervical cancer	6.51e-05	9.03e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TP53—cervical cancer	6.41e-05	8.88e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—EGFR—cervical cancer	6.3e-05	8.73e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TP53—cervical cancer	5.91e-05	8.19e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TP53—cervical cancer	5.81e-05	8.06e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TP53—cervical cancer	5.29e-05	7.33e-05	CbGpPWpGaD
